# Ralliant Corp: financial statements, quarterly

RAL · NYSE · CIK 2041385 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ral.md) · [Financials](/companies/ral/financials.md) · [Filings](/companies/ral/filings.md) · [Insiders](/companies/ral/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ral/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-29) | period not labelled (2024-06-28) | period not labelled (2024-09-27) | period not labelled (2024-12-31) | period not labelled (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [534](/filings/0002041385-25-000033.md) | [532](/filings/0002041385-25-000069.md) | [548 d](/filings/0002041385-26-000023.md) | [482](/filings/0002041385-26-000046.md) | [503](/filings/0002041385-26-000065.md) | [529](/filings/0002041385-25-000069.md) | [555 d](/filings/0002041385-26-000023.md) | [535](/filings/0002041385-26-000046.md) | [568](/filings/0002041385-26-000065.md) |
| Cost of revenue | $m | not reported | [259](/filings/0002041385-25-000033.md) | [252](/filings/0002041385-25-000069.md) | [266 d](/filings/0002041385-26-000023.md) | [238](/filings/0002041385-26-000046.md) | [255](/filings/0002041385-26-000065.md) | [261](/filings/0002041385-25-000069.md) | [275 d](/filings/0002041385-26-000023.md) | [262](/filings/0002041385-26-000046.md) | [275](/filings/0002041385-26-000065.md) |
| Gross profit | $m | not reported | [275](/filings/0002041385-25-000033.md) | [280](/filings/0002041385-25-000069.md) | [282 d](/filings/0002041385-26-000023.md) | [243](/filings/0002041385-26-000046.md) | [248](/filings/0002041385-26-000065.md) | [269](/filings/0002041385-25-000069.md) | [280 d](/filings/0002041385-26-000023.md) | [272](/filings/0002041385-26-000046.md) | [293](/filings/0002041385-26-000065.md) |
| Research and development | $m | not reported | [38.8](/filings/0002041385-25-000033.md) | [39.9](/filings/0002041385-25-000069.md) | [42.1 d](/filings/0002041385-26-000023.md) | [41.3](/filings/0002041385-26-000046.md) | [42.0](/filings/0002041385-26-000065.md) | [38.8](/filings/0002041385-25-000069.md) | [42.9 d](/filings/0002041385-26-000023.md) | [43.7](/filings/0002041385-26-000046.md) | [44.7](/filings/0002041385-26-000065.md) |
| Selling, general and administrative | $m | not reported | [131](/filings/0002041385-25-000033.md) | [129](/filings/0002041385-25-000069.md) | [138 d](/filings/0002041385-26-000023.md) | [128](/filings/0002041385-26-000046.md) | [147](/filings/0002041385-26-000065.md) | [178](/filings/0002041385-25-000069.md) | [163 d](/filings/0002041385-26-000023.md) | [161](/filings/0002041385-26-000046.md) | [166](/filings/0002041385-26-000065.md) |
| Operating income | $m | not reported | [105](/filings/0002041385-25-000033.md) | [111](/filings/0002041385-25-000069.md) | [102 d](/filings/0002041385-26-000023.md) | [73.8](/filings/0002041385-26-000046.md) | [58.9](/filings/0002041385-26-000065.md) | [52.0](/filings/0002041385-25-000069.md) | [(1,368) d](/filings/0002041385-26-000023.md) | [68.1](/filings/0002041385-26-000046.md) | [82.2](/filings/0002041385-26-000065.md) |
| Interest expense | $m | not reported | not reported | [0.0](/filings/0002041385-25-000069.md) | [0.0 d](/filings/0002041385-26-000023.md) | [0.0](/filings/0002041385-26-000046.md) | [0.0](/filings/0002041385-26-000065.md) | [16.3](/filings/0002041385-25-000069.md) | [16.0 d](/filings/0002041385-26-000023.md) | [14.7](/filings/0002041385-26-000046.md) | [13.8](/filings/0002041385-26-000065.md) |
| Income tax | $m | not reported | [14.4](/filings/0002041385-25-000033.md) | [20.0](/filings/0002041385-25-000069.md) | [19.0 d](/filings/0002041385-26-000023.md) | [9.4](/filings/0002041385-26-000046.md) | [11.3](/filings/0002041385-26-000065.md) | [(4.7)](/filings/0002041385-25-000069.md) | [(9.9) d](/filings/0002041385-26-000023.md) | [8.7](/filings/0002041385-26-000046.md) | [11.3](/filings/0002041385-26-000065.md) |
| Net income | $m | [116](/filings/0002041385-25-000069.md) | [64.8](/filings/0002041385-25-000069.md) | [90.9](/filings/0002041385-25-000069.md) | [82.7 d](/filings/0002041385-26-000023.md) | [63.9](/filings/0002041385-26-000065.md) | [47.6](/filings/0002041385-26-000065.md) | [39.9](/filings/0002041385-25-000069.md) | [(1,374) d](/filings/0002041385-26-000023.md) | [44.2](/filings/0002041385-26-000065.md) | [57.2](/filings/0002041385-26-000065.md) |
| Diluted EPS | $ per share | not reported | [0.57](/filings/0002041385-25-000033.md) | [0.81](/filings/0002041385-25-000069.md) | not reported | [0.57](/filings/0002041385-26-000046.md) | [0.42](/filings/0002041385-26-000065.md) | [0.35](/filings/0002041385-25-000069.md) | not reported | [0.39](/filings/0002041385-26-000046.md) | [0.51](/filings/0002041385-26-000065.md) |
| Basic EPS | $ per share | not reported | [0.57](/filings/0002041385-25-000033.md) | [0.81](/filings/0002041385-25-000069.md) | not reported | [0.57](/filings/0002041385-26-000046.md) | [0.42](/filings/0002041385-26-000065.md) | [0.35](/filings/0002041385-25-000069.md) | not reported | [0.39](/filings/0002041385-26-000046.md) | [0.51](/filings/0002041385-26-000065.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-29) | period not labelled (2024-06-28) | period not labelled (2024-09-27) | period not labelled (2024-12-31) | period not labelled (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0002041385-26-000023.md) | not reported | [199](/filings/0002041385-25-000033.md) | [264](/filings/0002041385-25-000069.md) | [319](/filings/0002041385-26-000065.md) | [268](/filings/0002041385-26-000046.md) | [271](/filings/0002041385-26-000065.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [619](/filings/0002041385-26-000023.md) | not reported | [847](/filings/0002041385-25-000033.md) | [977](/filings/0002041385-25-000069.md) | [976](/filings/0002041385-26-000065.md) | [930](/filings/0002041385-26-000046.md) | [972](/filings/0002041385-26-000065.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [4,719](/filings/0002041385-26-000023.md) | not reported | [5,177](/filings/0002041385-25-000033.md) | [5,265](/filings/0002041385-25-000069.md) | [3,822](/filings/0002041385-26-000065.md) | [3,697](/filings/0002041385-26-000046.md) | [3,706](/filings/0002041385-26-000065.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [534](/filings/0002041385-26-000023.md) | not reported | [533](/filings/0002041385-25-000033.md) | [657](/filings/0002041385-25-000069.md) | [1,160](/filings/0002041385-26-000065.md) | [579](/filings/0002041385-26-000046.md) | [638](/filings/0002041385-26-000065.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [957](/filings/0002041385-26-000023.md) | not reported | not reported | not reported | [2,187](/filings/0002041385-26-000065.md) | [2,131](/filings/0002041385-26-000046.md) | [2,172](/filings/0002041385-26-000065.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0002041385-26-000023.md) | not reported | [1,149](/filings/0002041385-25-000033.md) | [1,149](/filings/0002041385-25-000069.md) | [618](/filings/0002041385-26-000065.md) | [1,148](/filings/0002041385-26-000046.md) | [1,149](/filings/0002041385-26-000065.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0002041385-26-000023.md) | not reported | not reported | not reported | [530](/filings/0002041385-26-000065.md) | [0.0](/filings/0002041385-26-000046.md) | [0.0](/filings/0002041385-26-000065.md) |
| Shareholders' equity | $m | [2,259](/filings/0002041385-26-000023.md) | [2,261](/filings/0002041385-26-000023.md) | [3,994](/filings/0002041385-25-000069.md) | [3,982](/filings/0002041385-25-000069.md) | [4,004](/filings/0002041385-25-000069.md) | [3,763](/filings/0002041385-26-000065.md) | [3,847](/filings/0002041385-26-000065.md) | [3,040](/filings/0002041385-26-000065.md) | [2,964](/filings/0002041385-25-000069.md) | [1,634](/filings/0002041385-26-000065.md) | [1,566](/filings/0002041385-26-000065.md) | [1,534](/filings/0002041385-26-000065.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-27) | period not labelled (2024-12-31) | period not labelled (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [138 d](/filings/0002041385-25-000069.md) | [161 d](/filings/0002041385-26-000023.md) | [72.0](/filings/0002041385-26-000046.md) | [85.4 d](/filings/0002041385-26-000065.md) | [139 d](/filings/0002041385-25-000069.md) | [102 d](/filings/0002041385-26-000023.md) | [19.1](/filings/0002041385-26-000046.md) | [106 d](/filings/0002041385-26-000065.md) |
| Capital expenditure | $m | [6.1 d](/filings/0002041385-25-000069.md) | [14.5 d](/filings/0002041385-26-000023.md) | [5.6](/filings/0002041385-26-000046.md) | [11.6 d](/filings/0002041385-26-000065.md) | [12.0 d](/filings/0002041385-25-000069.md) | [10.0 d](/filings/0002041385-26-000023.md) | [8.7](/filings/0002041385-26-000046.md) | [6.4 d](/filings/0002041385-26-000065.md) |
| Dividends paid | $m | not reported | [0.0 d](/filings/0002041385-26-000023.md) | [0.0](/filings/0002041385-26-000046.md) | [0.0 d](/filings/0002041385-26-000065.md) | [5.6 d](/filings/0002041385-25-000069.md) | [5.7 d](/filings/0002041385-26-000023.md) | [5.6](/filings/0002041385-26-000046.md) | [5.5 d](/filings/0002041385-26-000065.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0002041385-26-000046.md) | [0.0 d](/filings/0002041385-26-000065.md) | not reported | not reported | [50.5](/filings/0002041385-26-000046.md) | [101 d](/filings/0002041385-26-000065.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-06-28) | period not labelled (2024-09-27) | period not labelled (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [113](/filings/0002041385-25-000033.md) | [113](/filings/0002041385-25-000069.md) | [113](/filings/0002041385-26-000046.md) | [113](/filings/0002041385-26-000065.md) | [113](/filings/0002041385-25-000069.md) | [113](/filings/0002041385-26-000046.md) | [113](/filings/0002041385-26-000065.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 110,640,008 at 2026-07-27, from the cover of the [10-Q filed 2026-07-30](/filings/0002041385-26-000065.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.